Video Experimental Relacionado
Updated: Jan 13, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Ingeniería de agentes de terapia fotodinámica basados en ε-polilisina con capacidades de transporte de oxígeno y de
Lianjun Mou1, Xiaoyan Lou2, Chang Liu2
1Department of Pathology, Hunan University of Medicine General Hospital Huaihua 418000 China.
Abstract:
Photodynamic therapy (PDT) offers exceptional spatial and temporal precision, minimal invasiveness, and negligible side effects. However, the hypoxic microenvironment of tumors greatly limits the effectiveness of conventional photodynamic therapy (PDT) and severely reduces its therapeutic efficiency. Here, a simple and versatile method for the preparation of PDT nanocomplexes based on ε-polylysine (PLY-1/2/3) was developed. By covalently combining a photosensitiser 5,10,15,20-tetra (4-carboxyl phenyl) porphyrin (H2TCPP), a biotin-targeting moiety (d-Bio) and an O2-carrying agent, perfluorohexanoic acid (PF-HA), the nanocomplex achieved specific targeting of HeLa cell membranes and was capable of efficiently generating cytotoxic singlet oxygen (1O2) in both normoxic and hypoxic conditions. Furthermore, O2-loaded PLY-1 had enhanced PDT efficacy, and it also showed a higher degree of apoptosis than the non-O2-loaded one. The results provided a facile and general method for the design and preparation of PDT composite against hypoxia.

